Condition: Impaired Glucose Regulation · Impaired Glucose Tolerance (Prediabetes) · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) · Sponsor: Leeds Beckett University
This 12-week, double-blind, placebo-controlled trial will examine whether daily supplementation with the Lab4P probiotic can improve cognitive performance and metabolic health in overweight adults aged 18 to 40 with impaired glucose tolerance, a preclinical condition where blood glucose regulation is mildly disrupted. Seventy participants will be randomly assigned to receive either Lab4P or a placebo. The study will assess changes in memory, executive function, and processing speed, along with blood glucose control, cardiovascular function, cholesterol levels, body composition, and markers of inflammation. The study will also analyse changes in the gut microbiome and evaluate the safety and tolerability of the probiotic.
This description comes directly from the study's public registry record.
Lewis F Hepburn · +447541333140 · l.hepburn3449@student.leedsbeckett.ac.uk
Always discuss trial participation with your own doctor first.
| Leeds Beckett University | Leeds, Greater Manchester, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07073781